Screener
Kura Oncology KURA Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Kura Oncology in its filing.
Tagged under the XBRL concept us-gaap:InterestAndOtherIncome.
The source filing: Kura Oncology’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219481
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Total operating expenses | 97,080 | 78,808 |
| Loss from operations | (78,815) | (64,700) |
| Other Income (Expense) | ||
| Interest and other income, net | 5,826 | 7,879 |
| Interest expense | (336) | (382) |
| Total other income, net | 5,490 | 7,497 |
| Loss before income taxes | (73,325) | (57,203) |
| Income tax expense | 8 | 226 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Kura Oncology's interest income?
- Kura Oncology (KURA) reported interest income of $5.83M in Q1 2026.
- How has Kura Oncology's interest income changed year-over-year?
- Kura Oncology's interest income decreased by 26.1% year-over-year, from $7.88M to $5.83M.
- What is the long-term trend for Kura Oncology's interest income?
- Over 4 years (2021 to 2025), Kura Oncology's interest income has grown at a 117.1% compound annual growth rate (CAGR), from $1.21M to $26.77M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about Kura Oncology's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude